Skip to main content
. 2024 Jan 6;47(6):1447ā€“1455. doi: 10.1007/s40618-023-02250-w

Fig. 4.

Fig. 4

Levels of Tr1 cells and therapy with GLP-1-RA in patients with T2DM. Blood samples from healthy controls, T2DM patients, untreated and receiving glucagon-like peptide-1 receptor agonists (GLP-1-RA), were analyzed for the levels of Tr1 lymphocytes, as indicated in Materials and Methods. Data correspond to the median and Q3 quartile. ns, non-significant; *pā€‰<ā€‰0.05